Martin Lagging

6.7k total citations
116 papers, 4.1k citations indexed

About

Martin Lagging is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Martin Lagging has authored 116 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Hepatology, 79 papers in Epidemiology and 27 papers in Infectious Diseases. Recurrent topics in Martin Lagging's work include Hepatitis C virus research (86 papers), Liver Disease Diagnosis and Treatment (61 papers) and Hepatitis B Virus Studies (50 papers). Martin Lagging is often cited by papers focused on Hepatitis C virus research (86 papers), Liver Disease Diagnosis and Treatment (61 papers) and Hepatitis B Virus Studies (50 papers). Martin Lagging collaborates with scholars based in Sweden, United States and Italy. Martin Lagging's co-authors include Keith Meyer, Gunnar Norkrans, Johan Westin, Ranjit Ray, Rune Wejstål, Kristoffer Hellstrand, Magnus Lindh, Stefan Zeuzem, Francesco Negro and Avidan U. Neumann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Martin Lagging

114 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Lagging Sweden 32 3.2k 2.8k 528 390 363 116 4.1k
Jean‐Pierre Zarski France 36 4.1k 1.3× 4.1k 1.5× 505 1.0× 310 0.8× 225 0.6× 144 5.3k
Jake T. Liang United States 29 3.2k 1.0× 3.8k 1.4× 518 1.0× 257 0.7× 560 1.5× 40 4.8k
J. Rasenack Germany 32 3.8k 1.2× 3.6k 1.3× 400 0.8× 361 0.9× 323 0.9× 71 4.9k
Andreas Cerny Switzerland 35 2.7k 0.8× 2.6k 0.9× 521 1.0× 397 1.0× 479 1.3× 102 4.7k
Takeshi Tanaka Japan 33 2.6k 0.8× 2.4k 0.9× 615 1.2× 270 0.7× 499 1.4× 100 4.3k
Takeji Umemura Japan 36 2.5k 0.8× 3.0k 1.1× 418 0.8× 840 2.2× 483 1.3× 223 4.8k
Jaw‐Ching Wu Taiwan 38 3.3k 1.0× 3.0k 1.1× 570 1.1× 188 0.5× 370 1.0× 145 4.9k
Norio Horiike Japan 35 2.2k 0.7× 2.2k 0.8× 300 0.6× 166 0.4× 269 0.7× 166 3.8k
Antonina Smedile Italy 41 6.6k 2.1× 6.7k 2.4× 592 1.1× 413 1.1× 502 1.4× 199 8.1k
Chuan–Mo Lee Taiwan 40 4.3k 1.3× 4.3k 1.5× 505 1.0× 236 0.6× 481 1.3× 122 5.9k

Countries citing papers authored by Martin Lagging

Since Specialization
Citations

This map shows the geographic impact of Martin Lagging's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lagging with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lagging more than expected).

Fields of papers citing papers by Martin Lagging

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Lagging. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lagging. The network helps show where Martin Lagging may publish in the future.

Co-authorship network of co-authors of Martin Lagging

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Lagging. A scholar is included among the top collaborators of Martin Lagging based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Lagging. Martin Lagging is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringlander, Johan, Anna Martner, Huiqi Li, et al.. (2025). Influence of viral load on severity and mortality in COVID-19. Infectious Diseases. 57(9). 811–818. 1 indexed citations
2.
Ringlander, Johan, Staffan Nilsson, Magnus Lindh, et al.. (2023). Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination. Clinical Immunology. 248. 109248–109248. 1 indexed citations
3.
Einarsdottir, Sigrun, J. Waldenström, Johan Ringlander, et al.. (2022). COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation. Haematologica. 107(10). 2492–2495.
4.
Wang, Hao, Staffan Nilsson, Martin Lagging, et al.. (2022). The amount of SARS-CoV-2 RNA in wastewater relates to the development of the pandemic and its burden on the health system. iScience. 25(9). 105000–105000. 8 indexed citations
5.
Longhi, Sonia, Oluf Andersen, Staffan Nilsson, et al.. (2014). Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production. Journal of Clinical Virology. 61(1). 107–112. 8 indexed citations
6.
Waldenström, J., Kristoffer Hellstrand, Staffan Nilsson, et al.. (2014). Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. Hepatology. 59(6). 2131–2139. 32 indexed citations
7.
Lagging, Martin, Mads Rauning Buhl, Peer Brehm Christensen, et al.. (2013). Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scandinavian Journal of Gastroenterology. 48(7). 839–847. 9 indexed citations
8.
Alsiö, Åsa, Peer Brehm Christensen, Martti Färkkilâ, et al.. (2012). Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3. PLoS ONE. 7(1). e29370–e29370. 31 indexed citations
9.
Lagging, Martin, Ann‐Sofi Duberg, Rune Wejstål, et al.. (2012). Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations. Scandinavian Journal of Infectious Diseases. 44(7). 502–521. 14 indexed citations
10.
Lagging, Martin, Galia Askarieh, Francesco Negro, et al.. (2011). Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms. PLoS ONE. 6(2). e17232–e17232. 122 indexed citations
11.
Fattovich, G., Loredana Covolo, Stéphanie Bibert, et al.. (2011). IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 33(10). 1162–1172. 82 indexed citations
12.
Lagging, Martin, Galia Askarieh, Pierre–Yves Bochud, et al.. (2010). Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C. IRIS. 2 indexed citations
13.
14.
Christensen, Peer Brehm, Åsa Alsiö, Mads Rauning Buhl, et al.. (2008). 10 RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR FOR SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT OF HEPATITIS C GENOTYPE 2/3 (NORDYNAMIC TRIAL). Journal of Hepatology. 48. S6–S7. 6 indexed citations
15.
Lagging, Martin, Nina Langeland, Court Pedersen, et al.. (2008). Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. Hepatology. 47(6). 1837–1845. 113 indexed citations
16.
Lagging, Martin, Ana I. Romero, Johan Westin, et al.. (2006). IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology. 44(6). 1617–1625. 179 indexed citations
17.
Orlent, Hans, Bettina E. Hansen, Marc Willems, et al.. (2006). Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial. Journal of Hepatology. 45(4). 539–546. 64 indexed citations
18.
Westin, Johan, Martin Lagging, Amar P. Dhillon, et al.. (2006). Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. Journal of Viral Hepatitis. 14(1). 29–35. 59 indexed citations
19.
Zeuzem, Stefan, Jean–Michel Pawlotsky, Michael Wagner, et al.. (2005). International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. Journal of Hepatology. 43(2). 250–257. 113 indexed citations
20.
Westin, Johan, Martin Lagging, Elisabeth Svensson, et al.. (2002). Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. Journal of Viral Hepatitis. 9(3). 235–241. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Zarski Breakdown of academic impact, for papers by Jake T. Liang Breakdown of academic impact, for papers by J. Rasenack Breakdown of academic impact, for papers by Andreas Cerny Breakdown of academic impact, for papers by Takeshi Tanaka Breakdown of academic impact, for papers by Takeji Umemura Breakdown of academic impact, for papers by Jaw‐Ching Wu Breakdown of academic impact, for papers by Norio Horiike Breakdown of academic impact, for papers by Antonina Smedile Breakdown of academic impact, for papers by Chuan–Mo Lee
Rankless by CCL
2026